Inventor
O'BRIEN MICHAEL ALISTAIR
GB23 patents
⚠️ This page may combine multiple inventors who share the name “O'BRIEN MICHAEL ALISTAIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
7 patentsUS7385059B2Jun 10, 2008
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD33 citations95
US7977477B2Jul 12, 2011
Benzimidazole derivatives and their use as protein kinase inhibitors
ASTEX THERAPEUTICS LTD35 citations92
US7754725B2Jul 13, 2010
Dihydroxyphenyl isoindolymethanones
ASTEX THERAPEUTICS LTD22 citations92
US7745638B2Jun 29, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD8 citations83
US7825140B2Nov 2, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD7 citations73
US9914719B2Mar 13, 2018
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
ASTEX THERAPEUTICS LTD0 citations51
US9051278B2Jun 9, 2015
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD0 citations51
HEPTARES THERAPEUTICS LTD
6 patentsUS9670183B2Jun 6, 2017
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD34 citations98
US10961225B2Mar 30, 2021
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD11 citations94
US10689368B2Jun 23, 2020
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD12 citations94
US10196380B2Feb 5, 2019
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD20 citations94
US9926297B2Mar 27, 2018
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD19 citations94
US10385039B2Aug 20, 2019
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
HEPTARES THERAPEUTICS LTD13 citations92
BERDINI VALERIO
4 patentsUS8895745B2Nov 25, 2014
Bicyclic heterocyclic compounds as FGFR inhibitors
BERDINI VALERIO33 citations92
US8513276B2Aug 20, 2013
Imidazo[1,2-a]pyridine compounds for use in treating cancer
BERDINI VALERIO8 citations82
US8080666B2Dec 20, 2011
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO6 citations73
US8779147B2Jul 15, 2014
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO2 citations62
CHESSARI GIANNI
3 patentsUS8106057B2Jan 31, 2012
Dihydroxyphenyl isoindolylmethanones
CHESSARI GIANNI19 citations91
US8101648B2Jan 24, 2012
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
CHESSARI GIANNI20 citations91
US8530469B2Sep 10, 2013
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
CHESSARI GIANNI11 citations82